Eagle Pharmaceuticals Inc (EGRX)
5.01
-0.03
(-0.60%)
USD |
NASDAQ |
Mar 27, 16:00
4.985
-0.02
(-0.50%)
After-Hours: 20:00
Eagle Pharmaceuticals Price: 5.01 for March 27, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 5.12 | 5.12 | 4.91 | 5.01 | 100640.0 |
Mar 26, 2024 | 5.15 | 5.185 | 5.02 | 5.04 | 51545.00 |
Mar 25, 2024 | 5.11 | 5.23 | 4.93 | 5.08 | 129342.0 |
Mar 22, 2024 | 5.21 | 5.25 | 4.90 | 5.05 | 159415.0 |
Mar 21, 2024 | 5.73 | 5.82 | 5.23 | 5.23 | 105056.0 |
Mar 20, 2024 | 5.51 | 5.77 | 5.39 | 5.68 | 99517.00 |
Mar 19, 2024 | 5.59 | 5.68 | 5.20 | 5.50 | 183207.0 |
Mar 18, 2024 | 5.95 | 6.19 | 5.54 | 5.62 | 144807.0 |
Mar 15, 2024 | 5.96 | 6.13 | 5.72 | 6.05 | 333544.0 |
Mar 14, 2024 | 6.08 | 6.09 | 5.78 | 5.95 | 102500.0 |
Mar 13, 2024 | 5.78 | 6.17 | 5.78 | 6.01 | 78657.00 |
Mar 12, 2024 | 5.94 | 5.94 | 5.58 | 5.73 | 153618.0 |
Mar 11, 2024 | 6.06 | 6.20 | 5.73 | 5.87 | 124565.0 |
Mar 08, 2024 | 6.28 | 6.50 | 6.237 | 6.25 | 73784.00 |
Mar 07, 2024 | 6.30 | 6.403 | 6.05 | 6.25 | 88434.00 |
Mar 06, 2024 | 6.60 | 6.74 | 6.22 | 6.35 | 64377.00 |
Mar 05, 2024 | 6.31 | 6.645 | 6.31 | 6.51 | 117107.0 |
Mar 04, 2024 | 6.70 | 6.70 | 6.13 | 6.29 | 128501.0 |
Mar 01, 2024 | 5.89 | 6.81 | 5.87 | 6.48 | 188309.0 |
Feb 29, 2024 | 6.26 | 6.44 | 5.73 | 5.86 | 154867.0 |
Feb 28, 2024 | 6.43 | 6.45 | 6.16 | 6.27 | 99594.00 |
Feb 27, 2024 | 6.50 | 6.65 | 6.232 | 6.44 | 113274.0 |
Feb 26, 2024 | 6.24 | 6.54 | 6.16 | 6.48 | 134242.0 |
Feb 23, 2024 | 5.85 | 6.32 | 5.745 | 6.25 | 166785.0 |
Feb 22, 2024 | 6.16 | 6.24 | 5.86 | 5.87 | 120517.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.26
Minimum
Jan 16 2024
64.31
Maximum
Nov 01 2019
39.96
Average
45.30
Median
Price Benchmarks
Inspire Medical Systems Inc | 213.50 |
Baxter International Inc | 42.69 |
NovaBay Pharmaceuticals Inc | 0.1112 |
Palatin Technologies Inc | 1.60 |
iBio Inc | 3.36 |
Price Related Metrics
PS Ratio | 0.2557 |
Price to Book Value | 0.2582 |
Earnings Yield | 18.16% |
Market Cap | 65.06M |
Operating PE Ratio | 1.606 |
Normalized PE Ratio | 5.506 |